Dr Mahmoud Barbir

MB BCh BAO  LRCPSI FRCP

Consultant Cardiologist

Cardiology

Coronary artery disease, cardiovascular disease

Coronary artery disease, refractory angina, hypertension, coronary risk factor detection and management, lipoprotein apheresis, genetic detection of familial hypercholesterolaemia, management of lipid disorders, cardiac rehabilitation, cardiac catherisation and CT coronary angiography

Dr Barbir graduated in 1980 at the Royal College of Surgeons in Ireland and did his initial training in general medicine and cardiology at St James' and Richmond Hospital in Dublin. In 1985, he started a British Heart Foundation research fellowship at Hammersmith Hospital for two years and subsequently completed three years training in clinical cardiology. In 1988 he worked at Harefield Hospital in clinical research under Professor Sir Magdi Yacoub and had further training in the department of cardiology until 1993, when he undertook his current consultant post. Dr Barbir has published more than 40 original manuscripts in medical journals, which include The Lancet, Circulation and The International Journal of Cardiology.

English, Arabic

Yes

Mon: eveTue: Wed: eveThurs: Fri: pmSat:

020 7460 5700

1980

Drug and Therapeutic Committee at the Trust, Working Group HEART UK on lipoprotein apheresis, NICE working party and Medical Board and Funding Committee for the Chain of Hope Charity.

Royal Brompton/Harefield

Hon Snr Lecturer, Dept of Medicine, Imperial College

Dr Barbir's major research interests are in familial hypercholesterolaemia, refractory angina, hyperlipidaemias, primary and secondary prevention, CT coronary calcification and angiography. He is currently involved in research on lipid lowering therapies; that includes lipoprotein apheresis (LDL apheresis); refractory angina and dyslipidaemia in transplant recipients.  Some of his research projects include: familial hypercholesterolaemia cascade study, cardiac rehabilitation for the treatment of refractory angina and syndrome X, role of computed tomography in risk assessment for coronary heart disease, improve-It study, LDL apheresis: indications and clinical experience in a tertiary centre and lipoprotein apheresis for refractory angina.

Mittal TK, Barbir M, Rubens M., Role of computed tomography in risk assessment for coronary heart disease.  Postgrad Med J. 2006 Oct;82(972):664-71 Review O'Rouke B, Barbir M, Mitchell AG, Yacoub MH, Banner Nr., Efficacy and safety of Fluvastatin therapy for hypercholesterolemia after heart transplantation, results of a randomised double blind placebo controlled study.  Int J Cardiol. 2004 Apr;94(2-3):235-40 Nakamura K, Al-Ruzzeh S, Chester AH, Schmidt I, Barbir M, Yacoub MH, Amrani M, Effects of Cerivastatin on vascular function of human radial and left internal thoracic arteries.  Ann Thorac Surg. 2002 Jun:73(6):1860-5:discussion 1865. Mohiaddin RH, McCrohon J, Francis JM, Barbir M, Pennell DJ. Contrast-enhanced magnetic resonance angiogram of penetrating aortic ulcer.  Circulation. 2001 Jan 30;103(4):E18-9 Barbir M, Lazem F, Ilsley C, et al., Coronary artery surgery in women compared with men: analysis of coronary risk factors and in-hospital mortality in a single centre.  Br Heart J. 1994 May;71(5):408-12